• 1
    Knight M, Kurinczuk JJ, Spark P, Brocklehurst P. United Kingdom Obstetrics Surveillance System (UKOSS) Annual Report 2007. Oxford: National Perinatal Epidemiology Unit, 2007.
  • 2
    Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998;31:16507.
  • 3
    Bédard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 2009;30:25665.
  • 4
    The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003;24:76181.
  • 5
    Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493537.
  • 6
    Hayman RG, Arulkumaran S, Steer PJ. Uterine compression sutures: surgical management of post-partum haemorrhage. Obstet Gynecol 2002;99:5026.
  • 7
    Phupong V, Ultchaswadi P, Charakorn C, Prammanee K, Prasertsri S, Charuluxananan S. Fatal maternal outcome of a parturient with Eisenmenger’s syndrome and pre eclampsia. Arch Gynecol Obstet 2003;267:1636.
  • 8
    Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, et al. Eisenmenger syndrome. Factors realting to deterioration and death. Eur Heart J 1998;19:184555.
  • 9
    Brach-Prever S, Sheppard M, Somerville J. Fatal outcome of pregnancy in the Eisenmenger syndrome. Cardiol Young 1997;7:23840.
  • 10
    Gatzoulis MA, Swan L, Therrien J, Pantely GA. Pulmonary hypertension. In: Gatzoulis MA, Swan L, Therrien J and Pantely G, editors. Adult Congenital Heart Disease: A Practical Guide. Oxford: Blackwell Publishing; 2005. 1828.
  • 11
    Yentis SM, Steer PJ, Plaat F. Eisenmenger’s syndrome in pregnancy: maternal and fetal mortality in the 1990s. Br J Obstet Gynaecol 1998;105:9212.
  • 12
    Siu SC, Sermer M, Harrison DA, Grigoriadis E, Liu G, Sorenson S, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997;96:278994.
  • 13
    Uebing A, Fischer G, Schlangen J, Apitz C, Steendijk P, Kramer HH. Can we use the end systolic volume index to monitor intrinsic right ventricular function after repair of tetralogy of fallot? Int J Cardiol 2011;147:527.
  • 14
    Tongers J, Schwerdtfeger B, Klein G, Kempf T, Schaefer A, Knapp J-M, et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 2007;153:12732.
  • 15
    Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000;356:97581.
  • 16
    Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marcon F, et al. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation 2004;109:19942000.
  • 17
    Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:51521.
  • 18
    Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation 2006;113:51724.
  • 19
    Bonnin M, Mercier FJ, Sitbon O, Roger-Christoph S, Jaïs X, Humbert M, et al. Severe pulmonary hypertension in pregnancy: mode of delivery and anaesthetic management of 15 consecutive cases. Anesthesiology 2005;102:11337; discussion 5A–6A.
  • 20
    Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:214857.
  • 21
    Curry R, Swan L, Steer PJ. Cardiac disease in pregnancy. Curr Opin Obstet Gynecol 2009;21:50813.
  • 22
    NICE Clinical Guidance. Caesarean Section. 2004. []. Last accessed 14 February 2012.
  • 23
    NICE Clinical Guidance. Intrapartum Care. 2008. []. Last accessed 14 February 2012.
  • 24
    Price LC, Forrest P, Sodhi V, Adamson DL, Nelson-Piercy C, Lucey M, et al. Use of vasopressin after caesarean section in idiopathic pulmonary arterial hypertension. Br J Anaesth 2007;99:5525.
  • 25
    Jonsson M, Hanson U, Lidell C, Norden-Lindeberg S. ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial. BJOG 2009;117:7683.
  • 26
    Svanstrom MC, Biber B, Hanes M, Johnasson G, Naslund U, Balfors EM. Signs of myocardial ischaemia after injection of oxytocin: a randomised controlled double-blind comparison of oxytocin and methylergometrine during caesarean section under spinal anaesthesia. Br J Anaesth 2008;100:6839.
  • 27
    Breen TW, Janzen JA. Pulmonary hypertension and cardiomyopathy: anaesthetic management for caesarean section. Can J Anaesth 1991;38:8959.
  • 28
    Gandhimathi K, Atkinson S, Gibson FM. Pulmonary hypertension complicating twin pregnancy: continuous spinal anaesthesia for caesarean section. Int J Obstet Anesth 2002;11:3015.
  • 29
    Olofsson C, Bremme K, Forssell G, Ohqvist G. Caesarean section under epidural ropivicaine 0.75% in a parturient with severe pulmonary hypertension. Acta Anaesthesiol Scand 2001;45:25860.
  • 30
    O’Hare R, McLoughlin C, Milligan K, Mcname D, Sidhu H. Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension. Br J Anaesth 1998;81:7902.
  • 31
    Mertens E, Saldien V, Coppejans H, Bettens K, Vercauteren M. Target controlled infusion of remifentanil and propofol for cesarean section in a patient with multivalvular disease and severe pulmonary hypertension. Acta Anaesthesiol Belg 2001;52:2079.
  • 32
    Monnery L, Nanson J, Charlton G. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth 2001;87:2958.
  • 33
    Blaise G, Langleben D, Hubert B. Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology 2003;99:141532.
  • 34
    Schulte-Sasse U, Hess W, Tarnow J. Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology 1982;57:913.
  • 35
    Kiely DG, Condliffe R, Webster V, Mills GH, Wrench I, Gandhi SV, et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG 2010;117:56574.